Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation

PaperCitations, authors & open-access status

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 54 citations, 2019 year and green oa status.

54
Citations
2019
Year
green
OA Status

Related on ScholarIQ

Stefano Mazza
Author
Transplantation
Journal
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Organ Transplantation Techniques and Outcomes
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
470M+ articles · free account